Biotechnology New Standard Of Care? IceCure Submits Final ICE3 Data To FDA, Minimally Invasive Cryoablation Shows Similar 5-year Recurrence Outcomes To Surgery With Hormone Therapy – Icecure Medical (NASDAQ:ICCM) Read more
Biotechnology Spruce Biosciences’ Hormone Treatment Stumbles In Trials, Prompts Stock Freefall Spruce Biosciences’ Hormonal Disorder Candidate’s Future in Limbo: Analysts Downgrade Amid Tildacerfont’s Trial Setback – Spruce Biosciences (NASDAQ:SPRB) Read more
Biotechnology What’s Going On With Stress Hormone Modulator-Focused Corcept Therapeutics’ Stock Friday? – Corcept Therapeutics (NASDAQ:CORT) Read more